Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1100
0.00 (0.00%)
Aug 3, 2026, 10:20 AM AEST

Invex Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
0.230.231.210.460.18-
Revenue Growth
0%-81.10%164.06%151.90%--
Gross Profit
0.230.231.210.460.18-
Operating Income
-1.08-0.71-2.13-8.55-4.03-2.44
Net Income
-0.84-0.48-1.64-7.75-3.95-2.28
Earnings Per Share
-0.01-0.01-0.02-0.10-0.05-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash (Debt)
4.65.386.0322.4729.3432.72
Net Cash Growth
-14.51%-10.79%-73.19%-23.41%-10.32%24.39%
Net Cash Per Share
0.060.070.080.300.390.44
Cash & Investments
4.65.386.0322.4729.3432.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-1.19-0.65-2.44-6.87-3.38-1.68
Free Cash Flow
-1.19-0.65-2.44-6.87-3.38-1.68
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-471.50%-309.63%-176.00%-1861.73%-2212.89%-
Pretax Margin
-364.89%-208.16%-135.43%-1688.11%-2169.06%-
Profit Margin
-364.90%-208.16%-135.43%-1688.11%-2169.06%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
36.0929.203.7232.74204.12-